Listed

Adma Biologics, Inc.

ADMANasdaqCIK 1368514HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$124.4m, Q2 FY2026
Operating income$52.4m, Q2 FY2026
Net income$37.8m, Q2 FY2026
Adma Biologics, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m67.3Revenue, Q3 FY2023, three months to 2023-09-30$67.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-07, accession 0001140361-24-045693.Report this figure73.9Revenue, Q4 FY2023, three months to 2023-12-31$73.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001140361-26-006815. Derived: 12-month figure less the 9-month figure.Report this figure81.9Revenue, Q1 FY2024, three months to 2024-03-31$81.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-07, accession 0001140361-25-017747.Report this figure107Revenue, Q2 FY2024, three months to 2024-06-30$107.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-06, accession 0001140361-25-029177.Report this figure120Revenue, Q3 FY2024, three months to 2024-09-30$119.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001140361-25-040578.Report this figure118Revenue, Q4 FY2024, three months to 2024-12-31$117.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001140361-26-006815. Derived: 12-month figure less the 9-month figure.Report this figure115Revenue, Q1 FY2025, three months to 2025-03-31$114.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001140361-26-019336.Report this figure122Revenue, Q2 FY2025, three months to 2025-06-30$122.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure134Revenue, Q3 FY2025, three months to 2025-09-30$134.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001140361-25-040578.Report this figure139Revenue, Q4 FY2025, three months to 2025-12-31$139.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001140361-26-006815. Derived: 12-month figure less the 9-month figure.Report this figure114Revenue, Q1 FY2026, three months to 2026-03-31$114.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001140361-26-019336.Report this figure124Revenue, Q2 FY2026, three months to 2026-06-30$124.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure
Cost of revenue$m42.6Cost of revenue, Q3 FY2023, three months to 2023-09-30$42.6m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2024-11-07, accession 0001140361-24-045693.Report this figure42.8Cost of revenue, Q4 FY2023, three months to 2023-12-31$42.8m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-02-25, accession 0001140361-26-006815. Derived: 12-month figure less the 9-month figure.Report this figure42.8Cost of revenue, Q1 FY2024, three months to 2024-03-31$42.8m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-05-07, accession 0001140361-25-017747.Report this figure49.7Cost of revenue, Q2 FY2024, three months to 2024-06-30$49.7m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-08-06, accession 0001140361-25-029177.Report this figure60.2Cost of revenue, Q3 FY2024, three months to 2024-09-30$60.2m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-05, accession 0001140361-25-040578.Report this figure54.2Cost of revenue, Q4 FY2024, three months to 2024-12-31$54.2m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-02-25, accession 0001140361-26-006815. Derived: 12-month figure less the 9-month figure.Report this figure53.7Cost of revenue, Q1 FY2025, three months to 2025-03-31$53.7m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-06, accession 0001140361-26-019336.Report this figure54.8Cost of revenue, Q2 FY2025, three months to 2025-06-30$54.8m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure58.6Cost of revenue, Q3 FY2025, three months to 2025-09-30$58.6m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-05, accession 0001140361-25-040578.Report this figure50.3Cost of revenue, Q4 FY2025, three months to 2025-12-31$50.3m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-02-25, accession 0001140361-26-006815. Derived: 12-month figure less the 9-month figure.Report this figure33.7Cost of revenue, Q1 FY2026, three months to 2026-03-31$33.7m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-06, accession 0001140361-26-019336.Report this figure38.1Cost of revenue, Q2 FY2026, three months to 2026-06-30$38.1m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure
Gross profit$m24.7Gross profit, Q3 FY2023, three months to 2023-09-30$24.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-07, accession 0001140361-24-045693.Report this figure31.1Gross profit, Q4 FY2023, three months to 2023-12-31$31.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-25, accession 0001140361-26-006815. Derived: 12-month figure less the 9-month figure.Report this figure39.1Gross profit, Q1 FY2024, three months to 2024-03-31$39.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-07, accession 0001140361-25-017747.Report this figure57.5Gross profit, Q2 FY2024, three months to 2024-06-30$57.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-06, accession 0001140361-25-029177.Report this figure59.7Gross profit, Q3 FY2024, three months to 2024-09-30$59.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-05, accession 0001140361-25-040578.Report this figure63.3Gross profit, Q4 FY2024, three months to 2024-12-31$63.3m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-25, accession 0001140361-26-006815. Derived: 12-month figure less the 9-month figure.Report this figure61.1Gross profit, Q1 FY2025, three months to 2025-03-31$61.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-06, accession 0001140361-26-019336.Report this figure67.2Gross profit, Q2 FY2025, three months to 2025-06-30$67.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure75.6Gross profit, Q3 FY2025, three months to 2025-09-30$75.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-05, accession 0001140361-25-040578.Report this figure88.8Gross profit, Q4 FY2025, three months to 2025-12-31$88.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-25, accession 0001140361-26-006815. Derived: 12-month figure less the 9-month figure.Report this figure80.8Gross profit, Q1 FY2026, three months to 2026-03-31$80.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-06, accession 0001140361-26-019336.Report this figure86.3Gross profit, Q2 FY2026, three months to 2026-06-30$86.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure
Research and development$m0.6Research and development, Q3 FY2023, three months to 2023-09-30$596.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0001140361-24-045693.Report this figure0.4Research and development, Q4 FY2023, three months to 2023-12-31$446.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-25, accession 0001140361-26-006815. Derived: 12-month figure less the 9-month figure.Report this figure0.5Research and development, Q1 FY2024, three months to 2024-03-31$450.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-07, accession 0001140361-25-017747.Report this figure0.6Research and development, Q2 FY2024, three months to 2024-06-30$560.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-06, accession 0001140361-25-029177.Report this figure0.4Research and development, Q3 FY2024, three months to 2024-09-30$412.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-05, accession 0001140361-25-040578.Report this figure0.4Research and development, Q4 FY2024, three months to 2024-12-31$391.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-25, accession 0001140361-26-006815. Derived: 12-month figure less the 9-month figure.Report this figure0.8Research and development, Q1 FY2025, three months to 2025-03-31$826.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-06, accession 0001140361-26-019336.Report this figure1.0Research and development, Q2 FY2025, three months to 2025-06-30$1.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure1.5Research and development, Q3 FY2025, three months to 2025-09-30$1.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-05, accession 0001140361-25-040578.Report this figure1.4Research and development, Q4 FY2025, three months to 2025-12-31$1.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-25, accession 0001140361-26-006815. Derived: 12-month figure less the 9-month figure.Report this figure2.6Research and development, Q1 FY2026, three months to 2026-03-31$2.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-06, accession 0001140361-26-019336.Report this figure6.0Research and development, Q2 FY2026, three months to 2026-06-30$6.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure
Selling, general and administrative$m14.7Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$14.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-07, accession 0001140361-24-045693.Report this figure15.5Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$15.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-25, accession 0001140361-26-006815. Derived: 12-month figure less the 9-month figure.Report this figure15.6Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$15.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-07, accession 0001140361-25-017747.Report this figure16.6Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$16.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-06, accession 0001140361-25-029177.Report this figure18.6Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$18.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-05, accession 0001140361-25-040578.Report this figure23.3Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$23.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-25, accession 0001140361-26-006815. Derived: 12-month figure less the 9-month figure.Report this figure24.1Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$24.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-06, accession 0001140361-26-019336.Report this figure22.2Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$22.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure21.8Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$21.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-05, accession 0001140361-25-040578.Report this figure23.5Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$23.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-25, accession 0001140361-26-006815. Derived: 12-month figure less the 9-month figure.Report this figure26.7Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$26.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-06, accession 0001140361-26-019336.Report this figure26.7Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$26.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure
Operating income$m8.7Operating income, Q3 FY2023, three months to 2023-09-30$8.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0001140361-24-045693.Report this figure14.2Operating income, Q4 FY2023, three months to 2023-12-31$14.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001140361-26-006815. Derived: 12-month figure less the 9-month figure.Report this figure21.8Operating income, Q1 FY2024, three months to 2024-03-31$21.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-07, accession 0001140361-25-017747.Report this figure39.2Operating income, Q2 FY2024, three months to 2024-06-30$39.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-06, accession 0001140361-25-029177.Report this figure39.6Operating income, Q3 FY2024, three months to 2024-09-30$39.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001140361-25-040578.Report this figure38.3Operating income, Q4 FY2024, three months to 2024-12-31$38.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001140361-26-006815. Derived: 12-month figure less the 9-month figure.Report this figure34.9Operating income, Q1 FY2025, three months to 2025-03-31$34.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001140361-26-019336.Report this figure42.8Operating income, Q2 FY2025, three months to 2025-06-30$42.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure51.0Operating income, Q3 FY2025, three months to 2025-09-30$51.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001140361-25-040578.Report this figure62.8Operating income, Q4 FY2025, three months to 2025-12-31$62.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001140361-26-006815. Derived: 12-month figure less the 9-month figure.Report this figure58.3Operating income, Q1 FY2026, three months to 2026-03-31$58.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001140361-26-019336.Report this figure52.4Operating income, Q2 FY2026, three months to 2026-06-30$52.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure
Interest expense$m6.4Interest expense, Q3 FY2023, three months to 2023-09-30$6.4m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-08, accession 0001140361-23-052109.Report this figure6.2Interest expense, Q4 FY2023, three months to 2023-12-31$6.2m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-02-28, accession 0001140361-24-010147. Derived: 12-month figure less the 9-month figure.Report this figure3.8Interest expense, Q1 FY2024, three months to 2024-03-31$3.8m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-09, accession 0001140361-24-025226.Report this figure3.8Interest expense, Q2 FY2024, three months to 2024-06-30$3.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-06, accession 0001140361-25-029177.Report this figure3.5Interest expense, Q3 FY2024, three months to 2024-09-30$3.5m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-05, accession 0001140361-25-040578.Report this figure2.9Interest expense, Q4 FY2024, three months to 2024-12-31$2.9m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-25, accession 0001140361-26-006815. Derived: 12-month figure less the 9-month figure.Report this figure2.0Interest expense, Q1 FY2025, three months to 2025-03-31$2.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-06, accession 0001140361-26-019336.Report this figure1.8Interest expense, Q2 FY2025, three months to 2025-06-30$1.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure1.7Interest expense, Q3 FY2025, three months to 2025-09-30$1.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-05, accession 0001140361-25-040578.Report this figure1.6Interest expense, Q4 FY2025, three months to 2025-12-31$1.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-25, accession 0001140361-26-006815. Derived: 12-month figure less the 9-month figure.Report this figure2.1Interest expense, Q1 FY2026, three months to 2026-03-31$2.1m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-06, accession 0001140361-26-019336.Report this figure3.4Interest expense, Q2 FY2026, three months to 2026-06-30$3.4m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-07, accession 0001140361-24-045693.Report this figure0.0Income tax, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-25, accession 0001140361-26-006815. Derived: 12-month figure less the 9-month figure.Report this figure0.6Income tax, Q1 FY2024, three months to 2024-03-31$595.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-07, accession 0001140361-25-017747.Report this figure3.8Income tax, Q2 FY2024, three months to 2024-06-30$3.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-06, accession 0001140361-25-029177.Report this figure0.8Income tax, Q3 FY2024, three months to 2024-09-30$840.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-05, accession 0001140361-25-040578.Report this figure(77.2)Income tax, Q4 FY2024, three months to 2024-12-31−$77.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-25, accession 0001140361-26-006815. Derived: 12-month figure less the 9-month figure.Report this figure6.5Income tax, Q1 FY2025, three months to 2025-03-31$6.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001140361-26-019336.Report this figure5.9Income tax, Q2 FY2025, three months to 2025-06-30$5.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure11.1Income tax, Q3 FY2025, three months to 2025-09-30$11.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-05, accession 0001140361-25-040578.Report this figure12.2Income tax, Q4 FY2025, three months to 2025-12-31$12.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-25, accession 0001140361-26-006815. Derived: 12-month figure less the 9-month figure.Report this figure11.8Income tax, Q1 FY2026, three months to 2026-03-31$11.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001140361-26-019336.Report this figure12.4Income tax, Q2 FY2026, three months to 2026-06-30$12.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure
Net income$m2.6Net income, Q3 FY2023, three months to 2023-09-30$2.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0001140361-24-045693.Report this figure(17.6)Net income, Q4 FY2023, three months to 2023-12-31−$17.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001140361-26-006815. Derived: 12-month figure less the 9-month figure.Report this figure17.8Net income, Q1 FY2024, three months to 2024-03-31$17.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001140361-25-040578.Report this figure32.1Net income, Q2 FY2024, three months to 2024-06-30$32.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001140361-25-040578.Report this figure35.9Net income, Q3 FY2024, three months to 2024-09-30$35.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001140361-25-040578.Report this figure112Net income, Q4 FY2024, three months to 2024-12-31$111.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001140361-26-006815. Derived: 12-month figure less the 9-month figure.Report this figure26.9Net income, Q1 FY2025, three months to 2025-03-31$26.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure34.2Net income, Q2 FY2025, three months to 2025-06-30$34.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure36.4Net income, Q3 FY2025, three months to 2025-09-30$36.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001140361-25-040578.Report this figure49.4Net income, Q4 FY2025, three months to 2025-12-31$49.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001140361-26-006815. Derived: 12-month figure less the 9-month figure.Report this figure45.3Net income, Q1 FY2026, three months to 2026-03-31$45.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure37.8Net income, Q2 FY2026, three months to 2026-06-30$37.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure
Diluted EPS$ per share0.01Diluted EPS, Q3 FY2023, three months to 2023-09-30$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0001140361-24-045693.Report this figurenot reported0.08Diluted EPS, Q1 FY2024, three months to 2024-03-31$0.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-07, accession 0001140361-25-017747.Report this figure0.13Diluted EPS, Q2 FY2024, three months to 2024-06-30$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-06, accession 0001140361-25-029177.Report this figure0.15Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.15 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001140361-25-040578.Report this figurenot reported0.11Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001140361-26-019336.Report this figure0.14Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure0.15Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.15 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001140361-25-040578.Report this figurenot reported0.19Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001140361-26-019336.Report this figure0.16Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure
Basic EPS$ per share0.01Basic EPS, Q3 FY2023, three months to 2023-09-30$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0001140361-24-045693.Report this figurenot reported0.08Basic EPS, Q1 FY2024, three months to 2024-03-31$0.08 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-07, accession 0001140361-25-017747.Report this figure0.14Basic EPS, Q2 FY2024, three months to 2024-06-30$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-06, accession 0001140361-25-029177.Report this figure0.15Basic EPS, Q3 FY2024, three months to 2024-09-30$0.15 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001140361-25-040578.Report this figurenot reported0.11Basic EPS, Q1 FY2025, three months to 2025-03-31$0.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001140361-26-019336.Report this figure0.14Basic EPS, Q2 FY2025, three months to 2025-06-30$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure0.15Basic EPS, Q3 FY2025, three months to 2025-09-30$0.15 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001140361-25-040578.Report this figurenot reported0.19Basic EPS, Q1 FY2026, three months to 2026-03-31$0.19 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001140361-26-019336.Report this figure0.17Basic EPS, Q2 FY2026, three months to 2026-06-30$0.17 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure

Balance sheet

Cash and equivalents$136.0m, Q2 FY2026
Long-term debt$192.8m, Q2 FY2026
Shareholders' equity$408.2m, Q2 FY2026
Adma Biologics, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m74.2Cash and equivalents, Q3 FY2023, at 2023-09-30$74.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-08, accession 0001140361-23-052109.Report this figure51.4Cash and equivalents, FY2023, at 2023-12-31$51.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-18, accession 0001140361-25-009257.Report this figure45.3Cash and equivalents, Q1 FY2024, at 2024-03-31$45.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-09, accession 0001140361-24-025226.Report this figure88.2Cash and equivalents, Q2 FY2024, at 2024-06-30$88.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-08, accession 0001140361-24-036432.Report this figure86.7Cash and equivalents, Q3 FY2024, at 2024-09-30$86.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0001140361-24-045693.Report this figure103Cash and equivalents, FY2024, at 2024-12-31$103.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-25, accession 0001140361-26-006815.Report this figure71.6Cash and equivalents, Q1 FY2025, at 2025-03-31$71.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-07, accession 0001140361-25-017747.Report this figure90.3Cash and equivalents, Q2 FY2025, at 2025-06-30$90.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-06, accession 0001140361-25-029177.Report this figure61.4Cash and equivalents, Q3 FY2025, at 2025-09-30$61.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-05, accession 0001140361-25-040578.Report this figure87.6Cash and equivalents, FY2025, at 2025-12-31$87.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure138Cash and equivalents, Q1 FY2026, at 2026-03-31$138.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-06, accession 0001140361-26-019336.Report this figure136Cash and equivalents, Q2 FY2026, at 2026-06-30$136.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure
Current assets$m274Current assets, Q3 FY2023, at 2023-09-30$273.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-08, accession 0001140361-23-052109.Report this figure257Current assets, FY2023, at 2023-12-31$257.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-18, accession 0001140361-25-009257.Report this figure276Current assets, Q1 FY2024, at 2024-03-31$276.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0001140361-24-025226.Report this figure304Current assets, Q2 FY2024, at 2024-06-30$303.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0001140361-24-036432.Report this figure318Current assets, Q3 FY2024, at 2024-09-30$318.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0001140361-24-045693.Report this figure331Current assets, FY2024, at 2024-12-31$331.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-25, accession 0001140361-26-006815.Report this figure352Current assets, Q1 FY2025, at 2025-03-31$351.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-07, accession 0001140361-25-017747.Report this figure400Current assets, Q2 FY2025, at 2025-06-30$399.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-06, accession 0001140361-25-029177.Report this figure403Current assets, Q3 FY2025, at 2025-09-30$402.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-05, accession 0001140361-25-040578.Report this figure467Current assets, FY2025, at 2025-12-31$466.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure511Current assets, Q1 FY2026, at 2026-03-31$511.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-06, accession 0001140361-26-019336.Report this figure528Current assets, Q2 FY2026, at 2026-06-30$528.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure
Total assets$m349Total assets, Q3 FY2023, at 2023-09-30$349.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0001140361-24-045693.Report this figure329Total assets, FY2023, at 2023-12-31$329.2m. XBRL concept us-gaap:Assets. 10-K filed 2026-02-25, accession 0001140361-26-006815.Report this figure351Total assets, Q1 FY2024, at 2024-03-31$350.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-07, accession 0001140361-25-017747.Report this figure376Total assets, Q2 FY2024, at 2024-06-30$376.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-06, accession 0001140361-25-029177.Report this figure391Total assets, Q3 FY2024, at 2024-09-30$390.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-05, accession 0001140361-25-040578.Report this figure489Total assets, FY2024, at 2024-12-31$488.7m. XBRL concept us-gaap:Assets. 10-K filed 2026-02-25, accession 0001140361-26-006815.Report this figure511Total assets, Q1 FY2025, at 2025-03-31$510.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-06, accession 0001140361-26-019336.Report this figure558Total assets, Q2 FY2025, at 2025-06-30$558.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure569Total assets, Q3 FY2025, at 2025-09-30$568.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-05, accession 0001140361-25-040578.Report this figure624Total assets, FY2025, at 2025-12-31$624.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure665Total assets, Q1 FY2026, at 2026-03-31$665.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-06, accession 0001140361-26-019336.Report this figure684Total assets, Q2 FY2026, at 2026-06-30$684.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure
Current liabilities$m41.8Current liabilities, Q3 FY2023, at 2023-09-30$41.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-08, accession 0001140361-23-052109.Report this figure49.8Current liabilities, FY2023, at 2023-12-31$49.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-18, accession 0001140361-25-009257.Report this figure53.1Current liabilities, Q1 FY2024, at 2024-03-31$53.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-09, accession 0001140361-24-025226.Report this figure44.2Current liabilities, Q2 FY2024, at 2024-06-30$44.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0001140361-24-036432.Report this figure44.9Current liabilities, Q3 FY2024, at 2024-09-30$44.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0001140361-24-045693.Report this figure55.5Current liabilities, FY2024, at 2024-12-31$55.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-25, accession 0001140361-26-006815.Report this figure53.5Current liabilities, Q1 FY2025, at 2025-03-31$53.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-07, accession 0001140361-25-017747.Report this figure74.9Current liabilities, Q2 FY2025, at 2025-06-30$74.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-06, accession 0001140361-25-029177.Report this figure56.5Current liabilities, Q3 FY2025, at 2025-09-30$56.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-05, accession 0001140361-25-040578.Report this figure69.5Current liabilities, FY2025, at 2025-12-31$69.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure73.5Current liabilities, Q1 FY2026, at 2026-03-31$73.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-06, accession 0001140361-26-019336.Report this figure75.8Current liabilities, Q2 FY2026, at 2026-06-30$75.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure
Total liabilities$m198Total liabilities, Q3 FY2023, at 2023-09-30$197.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-08, accession 0001140361-23-052109.Report this figure194Total liabilities, FY2023, at 2023-12-31$194.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-18, accession 0001140361-25-009257.Report this figure197Total liabilities, Q1 FY2024, at 2024-03-31$197.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-09, accession 0001140361-24-025226.Report this figure188Total liabilities, Q2 FY2024, at 2024-06-30$188.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0001140361-24-036432.Report this figure159Total liabilities, Q3 FY2024, at 2024-09-30$158.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0001140361-24-045693.Report this figure140Total liabilities, FY2024, at 2024-12-31$139.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-25, accession 0001140361-26-006815.Report this figure137Total liabilities, Q1 FY2025, at 2025-03-31$137.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-07, accession 0001140361-25-017747.Report this figure160Total liabilities, Q2 FY2025, at 2025-06-30$160.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-06, accession 0001140361-25-029177.Report this figure138Total liabilities, Q3 FY2025, at 2025-09-30$137.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-05, accession 0001140361-25-040578.Report this figure147Total liabilities, FY2025, at 2025-12-31$146.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure275Total liabilities, Q1 FY2026, at 2026-03-31$274.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-06, accession 0001140361-26-019336.Report this figure276Total liabilities, Q2 FY2026, at 2026-06-30$276.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reported72.3Long-term debt, FY2024, at 2024-12-31$72.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-02-25, accession 0001140361-26-006815.Report this figurenot reportednot reported70.1Long-term debt, Q3 FY2025, at 2025-09-30$70.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-05, accession 0001140361-25-040578.Report this figure69.3Long-term debt, FY2025, at 2025-12-31$69.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure194Long-term debt, Q1 FY2026, at 2026-03-31$193.6m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-06, accession 0001140361-26-019336.Report this figure193Long-term debt, Q2 FY2026, at 2026-06-30$192.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure
Current portion of debt$mnot reportednot reportednot reportednot reportednot reported0.0Current portion of debt, FY2024, at 2024-12-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2026-02-25, accession 0001140361-26-006815.Report this figurenot reportednot reported2.3Current portion of debt, Q3 FY2025, at 2025-09-30$2.3m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-11-05, accession 0001140361-25-040578.Report this figure2.8Current portion of debt, FY2025, at 2025-12-31$2.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure3.3Current portion of debt, Q1 FY2026, at 2026-03-31$3.3m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-05-06, accession 0001140361-26-019336.Report this figure3.8Current portion of debt, Q2 FY2026, at 2026-06-30$3.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure
Shareholders' equity$m151Shareholders' equity, Q3 FY2023, at 2023-09-30$151.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0001140361-24-045693.Report this figure135Shareholders' equity, FY2023, at 2023-12-31$135.2m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-25, accession 0001140361-26-006815.Report this figure154Shareholders' equity, Q1 FY2024, at 2024-03-31$153.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001140361-25-040578.Report this figure188Shareholders' equity, Q2 FY2024, at 2024-06-30$188.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001140361-25-040578.Report this figure232Shareholders' equity, Q3 FY2024, at 2024-09-30$231.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001140361-25-040578.Report this figure349Shareholders' equity, FY2024, at 2024-12-31$349.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure373Shareholders' equity, Q1 FY2025, at 2025-03-31$373.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure398Shareholders' equity, Q2 FY2025, at 2025-06-30$398.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure431Shareholders' equity, Q3 FY2025, at 2025-09-30$431.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001140361-25-040578.Report this figure477Shareholders' equity, FY2025, at 2025-12-31$477.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure390Shareholders' equity, Q1 FY2026, at 2026-03-31$390.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure408Shareholders' equity, Q2 FY2026, at 2026-06-30$408.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure

Cash flow

Operating cash flow$29.5m, Q2 FY2026
Capital expenditure$2.3m, Q2 FY2026
Share repurchases$25.1m, Q2 FY2026
Adma Biologics, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m12.0Operating cash flow, Q3 FY2023, three months to 2023-09-30$12.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0001140361-24-045693. Derived: 9-month figure less the 6-month figure.Report this figure17.6Operating cash flow, Q4 FY2023, three months to 2023-12-31$17.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001140361-26-006815. Derived: 12-month figure less the 9-month figure.Report this figure(2.2)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$2.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-07, accession 0001140361-25-017747.Report this figure45.6Operating cash flow, Q2 FY2024, three months to 2024-06-30$45.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-06, accession 0001140361-25-029177. Derived: 6-month figure less the 3-month figure.Report this figure25.0Operating cash flow, Q3 FY2024, three months to 2024-09-30$25.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001140361-25-040578. Derived: 9-month figure less the 6-month figure.Report this figure50.2Operating cash flow, Q4 FY2024, three months to 2024-12-31$50.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001140361-26-006815. Derived: 12-month figure less the 9-month figure.Report this figure(19.7)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$19.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001140361-26-019336.Report this figure21.1Operating cash flow, Q2 FY2025, three months to 2025-06-30$21.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001140361-26-031445. Derived: 6-month figure less the 3-month figure.Report this figure13.3Operating cash flow, Q3 FY2025, three months to 2025-09-30$13.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001140361-25-040578. Derived: 9-month figure less the 6-month figure.Report this figure35.6Operating cash flow, Q4 FY2025, three months to 2025-12-31$35.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001140361-26-006815. Derived: 12-month figure less the 9-month figure.Report this figure58.2Operating cash flow, Q1 FY2026, three months to 2026-03-31$58.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001140361-26-019336.Report this figure29.5Operating cash flow, Q2 FY2026, three months to 2026-06-30$29.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001140361-26-031445. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.8Capital expenditure, Q3 FY2023, three months to 2023-09-30$757.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-07, accession 0001140361-24-045693. Derived: 9-month figure less the 6-month figure.Report this figure1.2Capital expenditure, Q4 FY2023, three months to 2023-12-31$1.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0001140361-26-006815. Derived: 12-month figure less the 9-month figure.Report this figure2.3Capital expenditure, Q1 FY2024, three months to 2024-03-31$2.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-07, accession 0001140361-25-017747.Report this figure2.1Capital expenditure, Q2 FY2024, three months to 2024-06-30$2.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-06, accession 0001140361-25-029177. Derived: 6-month figure less the 3-month figure.Report this figure1.1Capital expenditure, Q3 FY2024, three months to 2024-09-30$1.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001140361-25-040578. Derived: 9-month figure less the 6-month figure.Report this figure2.8Capital expenditure, Q4 FY2024, three months to 2024-12-31$2.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0001140361-26-006815. Derived: 12-month figure less the 9-month figure.Report this figure4.7Capital expenditure, Q1 FY2025, three months to 2025-03-31$4.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001140361-26-019336.Report this figure2.4Capital expenditure, Q2 FY2025, three months to 2025-06-30$2.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001140361-26-031445. Derived: 6-month figure less the 3-month figure.Report this figure14.4Capital expenditure, Q3 FY2025, three months to 2025-09-30$14.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001140361-25-040578. Derived: 9-month figure less the 6-month figure.Report this figure1.1Capital expenditure, Q4 FY2025, three months to 2025-12-31$1.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0001140361-26-006815. Derived: 12-month figure less the 9-month figure.Report this figure2.5Capital expenditure, Q1 FY2026, three months to 2026-03-31$2.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001140361-26-019336.Report this figure2.3Capital expenditure, Q2 FY2026, three months to 2026-06-30$2.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001140361-26-031445. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$mnot reportednot reportednot reportednot reportednot reported0.0Share repurchases, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-25, accession 0001140361-26-006815. Derived: 12-month figure less the 9-month figure.Report this figure0.0Share repurchases, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-06, accession 0001140361-26-019336.Report this figure0.0Share repurchases, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-05, accession 0001140361-26-031445. Derived: 6-month figure less the 3-month figure.Report this figure23.0Share repurchases, Q3 FY2025, three months to 2025-09-30$23.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-05, accession 0001140361-25-040578. Derived: 9-month figure less the 6-month figure.Report this figure8.9Share repurchases, Q4 FY2025, three months to 2025-12-31$8.9m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-25, accession 0001140361-26-006815. Derived: 12-month figure less the 9-month figure.Report this figure130Share repurchases, Q1 FY2026, three months to 2026-03-31$130.2m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-06, accession 0001140361-26-019336.Report this figure25.1Share repurchases, Q2 FY2026, three months to 2026-06-30$25.1m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-05, accession 0001140361-26-031445. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)230.34m, Q2 FY2026
Adma Biologics, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares196Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30196,383,935 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-08, accession 0001140361-23-052109.Report this figure222Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31221,921,750 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-09, accession 0001140361-24-025226.Report this figure223Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30222,683,393 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0001140361-24-036432.Report this figure234Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30233,761,262 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0001140361-24-045693.Report this figure236Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31236,414,374 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-07, accession 0001140361-25-017747.Report this figure242Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30242,167,072 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-06, accession 0001140361-25-029177.Report this figure245Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30244,804,065 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-05, accession 0001140361-25-040578.Report this figure245Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31244,676,350 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001140361-26-019336.Report this figure249Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30248,608,460 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure245Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30244,664,263 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-05, accession 0001140361-25-040578.Report this figure240Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31239,955,762 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001140361-26-019336.Report this figure230Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30230,337,048 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure

Shares outstanding: 223.98mShares outstanding, period not labelled, at 2026-07-31223,984,680 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-05, accession 0001140361-26-031445.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 5, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. Listed shows no prices and gives no investment advice.